Literature DB >> 4369040

Prevention of the generalized Shwartzman reaction and endotoxin lethality by polymyxin B localized in tissues.

W A Craig, J H Turner, C M Kunin.   

Abstract

Pretreatment with multiple doses of polymyxin B and colistimethate was evaluated as to its ability to sequester sufficient antibiotic in tissues to neutralize the effects of endotoxin in three animal models. Animals were challenged with endotoxin 24, 48, or 72 h after the last dose of antibiotic when there was minimal or not detectable drug in serum. Pretreatment with polymyxin B was successful in preventing the generalized Shwartzman reaction in rabbits and reducing endotoxin lethality in mice; however, large doses (20 mg per kg per day for 2 or 4 days) were required. Prolongation by more than 24 h of the interval between the last dose of polymyxin B and endotoxin challenge resulted in reduction or loss of protection. Dogs were unable to tolerate the high polymyxin B dosage which was protective in the mouse and rabbit. Lower, nontoxic doses of polymyxin B in dogs did not prevent endotoxin shock and lethality, even when challenged as soon as 1 h after the last dose. Pretreatment with colistimethate was ineffective in all three animal models.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4369040      PMCID: PMC414993          DOI: 10.1128/iai.10.2.287-292.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Studies with radioactive endotoxin. III. The effect of tolerance on the distribution of radioactivity after intravenous injection of Escherichia coli endotoxin labeled with Cr51.

Authors:  F J CAREY; A I BRAUDE; M ZALESKY
Journal:  J Clin Invest       Date:  1958-03       Impact factor: 14.808

2.  Dynamics of binding and release of the polymyxin antibiotics by tissues.

Authors:  W A Craig; C M Kunin
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

3.  Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body.

Authors:  C M Kunin; A Bugg
Journal:  J Infect Dis       Date:  1971-10       Impact factor: 5.226

4.  Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulfate.

Authors:  J J Corrigan; B M Bell
Journal:  J Lab Clin Med       Date:  1971-05

5.  Recovery of tissue bound polymyxin B and colistimethate.

Authors:  C M Kunin; A Bugg
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

6.  Binding of antibiotics to tissue homogenates.

Authors:  C M Kunin
Journal:  J Infect Dis       Date:  1970-01       Impact factor: 5.226

7.  Temporal protection of chick embryo against endotoxin by isoproterenol, polymyxin B sulfate, and hydrocortisone.

Authors:  R P Gruninger; C W Howe
Journal:  Proc Soc Exp Biol Med       Date:  1969-04

8.  Neutralization of the Shwartzman reactions by polymyxins B.

Authors:  D Rifkind; R B Hill
Journal:  J Immunol       Date:  1967-09       Impact factor: 5.422

9.  Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia.

Authors:  J J Corrigan; B M Bell
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

10.  Neutralization of endotoxin toxicity in chick embryos by antibiotics.

Authors:  D Rifkind; J D Palmer
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

View more
  17 in total

1.  Antibiotics and endotoxic shock.

Authors:  W R McCabe
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide.

Authors:  H S Warren; S A Kania; G R Siber
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

3.  Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B.

Authors:  T Butler; G Möller
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Effect of polymyxin B on gram-negative bacterial infection during pregnancy.

Authors:  Mukesh Kumar Jaiswal; Varkha Agrawal; Yogesh Kumar Jaiswal
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-06-01

5.  Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.

Authors:  B Hughes; B R Madan; J R Parratt
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

6.  Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.

Authors:  M Cooperstock; L Riegle
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

7.  Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis.

Authors:  Y Adachi; M Enomoto; M Adachi; M Suwa; Y Nagamine; T Nanno; T Hashimoto; H Inoue; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1982-12

8.  Polymyxins as inhibitors of polyclonal B-cell activators in murine lymphocyte cultures.

Authors:  T Butler; E Smith; L Hammarström; G Möller
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

9.  The in vivo effect of lipopolysaccharide on the spontaneous release of transmitter from motor nerve terminals.

Authors:  S H Liu; T J Sheu; R H Lin; S Y Lin-Shiau
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide.

Authors:  A Focà; G Matera; D Iannello; M C Berlinghieri; M C Liberto
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.